QA: Metavia Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001638287_2022_Metavia_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 9, '00205 - Statement - Condensed Statements of Comprehensive Loss (Calc 2)': 2}}

Graph

Absolute values for 0001638287, Metavia Inc

  xvar xval
0 AssetsCurrent 16,584,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 110,000
3 remainder_Assets 105,000
4 LiabilitiesCurrent 2,157,000
5 LiabilitiesNoncurrent 45,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,784,266
9 ResearchAndDevelopmentExpense 9,122,783
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 14,577
13 remainder_ComprehensiveNetIncome -11,288
  yvar yval
0 Assets 16,799,000
1 Liabilities 2,202,000
2 Expenses 17,907,049
3 Revenues 0
4 StockholdersEquity 14,597,000
5 NetIncome -17,892,472
6 ComprehensiveNetIncome -17,898,116
7 BaseVar 18,466,957
8 EconomicCapitalRatiobeforeLimitedLiability 1.47
9 EconomicCapitalRatio 2.65

Edgar->Model Mapping

Feature Distribution

Change over Time